Does cigarette reduction while using nicotine replacement therapy prior to a quit attempt predict abstinence following quit date?

Addiction

Volumn 111, Issue 7, 2016, Pages 1275-1282

  Lindson Hawley, Nicola ^a,b   Shinkins, Bethany ^a   West, Robert ^b,c   Michie, Susan ^b,c   Aveyard, Paul ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

NRT; observational; RCT; Reduction; smoking cessation; tobacco addiction

Indexed keywords

CARBON MONOXIDE; NICOTINE GUM;

ADULT; AGED; BREATH ANALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROCEDURES; PROGNOSIS; SMOKING; SMOKING CESSATION; THERAPY; TOBACCO; UNITED KINGDOM;

ADULT; AGED; BREATH TESTS; CARBON MONOXIDE; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROGNOSIS; SMOKING; SMOKING CESSATION; TOBACCO PRODUCTS; TOBACCO SMOKING; TOBACCO USE CESSATION PRODUCTS; UNITED KINGDOM;

EID: 85027939508     PISSN: None     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13330     Document Type: Article

References (16)

1. Rose J. E., Behm F. M., Westman E. C., Kukovich P. Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob Res 2006; 8: 89–101.
2. Rose J. E., Herskovic J. E., Behm F. M., Westman E. C. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment. Nicotine Tob Res 2009; 11: 1067–75.
3. Rose J. E., Behm F. M., Drgon T., Johnson C., Uhl G. R. Personalized smoking cessation: Interactions between nicotine dose, dependence and quit-success genotype score. Mol Med 2010; 16: 247–53.
4. Rose J. E., Behm F. M. Adapting smoking cessation treatment according to initial response to precessation nicotine patch. Am J Psychiatry 2013; 170: 860–7.
5. Hajek P., McRobbie H. J., Myers K. E., Stapleton J., Dhanji A.-R. Use of varenicline for 4 weeks before quitting smoking: Decrease in ad lib smoking and increase in smoking cessation rates. Arch Intern Med 2011; 171: 770–7.
6. Munafo M., Matheson I., Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: A meta-analysis of case–control studies and evidence of publication bias. Mol Psychiatry 2007; 12: 454–61.
7. Klemperer E. M., Hughes J. R. Does the magnitude of reduction in cigarettes per day predict smoking cessation? A qualitative review. Nicotine Tob Res 2016; 18: 88–92.
8. Lindson N., Aveyard P., Ingram J. T., Inglis J., Beach J., West R., et al. Rapid reduction versus abrupt quitting for smokers who want to stop soon: A randomised controlled noninferiority trial. Trials 2009; 10: 69–82.
9. West R., Hajek P., Stead L., Stapleton J. Outcome criteria in smoking cessation trials: Proposal for a common standard. Addiction 2005; 100: 299–303.
10. Heatherton T. F., Kozlowski L. T., Frecker R.C., Fagerstrom K.O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86: 1119–27.
11. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström Test for Cigarette Dependence. Nicotine Tob Res 2012; 14: 75–8.
12. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702–6.
13. Hajek P., McRobbie H., Myers Smith K., Phillips A., Cornwall A., Dhanji A. R. Increasing varenicline dose in smokers who do not respond to the standard dosage: A randomized clinical trial. JAMA Intern Med 2015; 175: 266–71.
14. Hughes John R., Stead Lindsay F., Hartmann-Boyce J., Cahill K., Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2014; Issue 1. Art. No.: CD000031. DOI: 10.1002/14651858.CD000031.pub4.
15. Cahill K., Stead Lindsay F., Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012.
16. Aveyard P., Brown K., Saunders C., Alexander A., Johnstone E., Munafó M. R. Weekly versus basic smoking cessation support in primary care: A randomised controlled trial. Thorax 2007; 62: 898–903.